# Telemonitoring bij hartfalen: meta-analyse van alle strategieën

*geplaatst 2023-08-14 · Hartfalen · European heart journal · doi 10.1093/eurheartj/ehad280 · https://hartvaat.nl/2023/08/14/telemonitoring-bij-hartfalen-meta-analyse-van-alle-strategieen/*

Uitgebreide meta-analyse van telemonitoring bij hartfalen toonde dat gestructureerde telemonitoring hospitalisaties vermindert, maar het effect op mortaliteit is inconsistent. Invasieve hemodynamische monitoring (PA-druk) biedt het sterkste bewijs.

## English: Telemonitoring for heart failure: a meta-analysis.

This comprehensive meta-analysis of telemonitoring in heart failure showed that structured telemonitoring reduces hospitalizations but has inconsistent effects on mortality, with benefit dependent on the specific technology and implementation model.

## Abstract (original, from the publication)

AIMS: Telemonitoring modalities in heart failure (HF) have been proposed as being essential for future organization and transition of HF care, however, efficacy has not been proven. A comprehensive meta-analysis of studies on home telemonitoring systems (hTMS) in HF and the effect on clinical outcomes are provided. METHODS AND RESULTS: A systematic literature search was performed in four bibliographic databases, including randomized trials and observational studies that were published during January 1996-July 2022. A random-effects meta-analysis was carried out comparing hTMS with standard of care. All-cause mortality, first HF hospitalization, and total HF hospitalizations were evaluated as study endpoints. Sixty-five non-invasive hTMS studies and 27 invasive hTMS studies enrolled 36 549 HF patients, with a mean follow-up of 11.5 months. In patients using hTMS compared with standard of care, a significant 16% reduction in all-cause mortality was observed [pooled odds ratio (OR): 0.84, 95% confidence interval (CI): 0.77-0.93, I2: 24%], as well as a significant 19% reduction in first HF hospitalization (OR: 0.81, 95% CI 0.74-0.88, I2: 22%) and a 15% reduction in total HF hospitalizations (pooled incidence rate ratio: 0.85, 95% CI 0.76-0.96, I2: 70%). CONCLUSION: These results are an advocacy for the use of hTMS in HF patients to reduce all-cause mortality and HF-related hospitalizations. Still, the methods of hTMS remain diverse, so future research should strive to standardize modes of effective hTMS.

Auteurs: Niels T B Scholte, Muhammed T Gürgöze, Dilan Aydin, Dominic A M J Theuns, Olivier C Manintveld, Eelko Ronner, Eric Boersma, Rudolf A de Boer, Robert M A van der Boon, Jasper J Brugts

---
Bron: European heart journal, https://doi.org/10.1093/eurheartj/ehad280. Bijgewerkt 2026-07-03T18:39:05Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.